Literature DB >> 31571232

Corrigendum to "Revised FIGO staging for carcinoma of the cervix uteri" [Int J Gynecol Obstet 145(2019) 129-135].

.   

Abstract

Entities:  

Year:  2019        PMID： 31571232     DOI： 10.1002/ijgo.12969

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  16 in total

1.  Activating transcription factor 3 inhibits endometrial carcinoma aggressiveness via JunB suppression.

Authors:  Fangyuan Wang; Jingjing Li; Haixia Wang; Fan Zhang; Jin Gao
Journal:  Int J Oncol       Date:  2020-06-19       Impact factor: 5.650

2.  The Clinical Impact of Low-Volume Lymph Nodal Metastases in Early-Stage Cervical Cancer: The Senticol 1 and Senticol 2 Trials.

Authors:  Benedetta Guani; Vincent Balaya; Laurent Magaud; Fabrice Lecuru; Patrice Mathevet
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

3.  Hydronephrosis in patients with cervical cancer is an indicator of poor outcome: A nationwide population-based retrospective cohort study.

Authors:  You-Rong Yang; Szu-Ju Chen; Pin-Yeh Yen; Chi-Ping Huang; Lu-Ting Chiu; Wu-Chou Lin; Huey-Yi Chen; Yung-Hsiang Chen; Wen-Chi Chen
Journal:  Medicine (Baltimore)       Date:  2021-02-12       Impact factor: 1.817

Review 4.  Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.

Authors:  Kay J Park; Andres Roma; Naveena Singh; C Blake Gilks; Esther Oliva; Nadeem Abu-Rustum; Pedro T Ramirez; W Glenn McCluggage
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

5.  Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial.

Authors:  Guillaume Favre; Benedetta Guani; Vincent Balaya; Laurent Magaud; Fabrice Lecuru; Patrice Mathevet
Journal:  Front Oncol       Date:  2021-02-17       Impact factor: 6.244

6.  Diagnostic Value of 18F-FDG PET/MRI for Revised 2018 FIGO Staging in Patients with Cervical Cancer.

Authors:  Hideaki Tsuyoshi; Tetsuya Tsujikawa; Shizuka Yamada; Hidehiko Okazawa; Yoshio Yoshida
Journal:  Diagnostics (Basel)       Date:  2021-01-29

7.  The Silva Pattern-based Classification for HPV-associated Invasive Endocervical Adenocarcinoma and the Distinction Between In Situ and Invasive Adenocarcinoma: Relevant Issues and Recommendations From the International Society of Gynecological Pathologists.

Authors:  Isabel Alvarado-Cabrero; Carlos Parra-Herran; Simona Stolnicu; Andres Roma; Esther Oliva; Anais Malpica
Journal:  Int J Gynecol Pathol       Date:  2021-03-01       Impact factor: 3.326

8.  The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.

Authors:  E Yang; Shuying Huang; Xuting Ran; Yue Huang; Zhengyu Li
Journal:  BMC Cancer       Date:  2021-02-27       Impact factor: 4.430

9.  Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009.

Authors:  Yunqiang Zhang; Jingxin Ding; Keqin Hua
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

10.  Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer-A Propensity Score Matching Analysis.

Authors:  Weili Li; Wenling Zhang; Lixin Sun; Li Wang; Zhumei Cui; Hongwei Zhao; Danbo Wang; Yi Zhang; Jianxin Guo; Ying Yang; Wuliang Wang; Xiaonong Bin; Jinghe Lang; Ping Liu; Chunlin Chen
Journal:  Front Oncol       Date:  2021-09-13       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.